0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(12):1192. doi:10.1001/jama.2014.3085.

JAMA | 
Viewpoint | 
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA. 2014;311(4):353-354. doi:10.1001/jama.2013.284531.

JAMA | 
Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(3):233-234. doi:10.1001/jama.2013.284833.

JAMA Dermatology | 
Case Report/Case Series | 
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.
JAMA Dermatol. 2013;149(12):1403-1406. doi:10.1001/jamadermatol.2013.8198.

JAMA Ophthalmology | 
Original Investigation | 
Megan M. McLaughlin, MS; Marcella G. Paglione, PharmD; Jason Slakter, MD; et al.
JAMA Ophthalmol. 2013;131(12):1595-1601. doi:10.1001/jamaophthalmol.2013.5002.

JAMA Dermatology | 
Original Investigation | 
Marc Julià, MD; Antonio Guilabert, MD; Francisco Lozano, MD; et al.
JAMA Dermatol. 2013;149(9):1033-1039. doi:10.1001/jamadermatol.2013.4632.

JAMA Psychiatry | 
Original Investigation | 
Giuseppe Blasi, MD, PhD; Caterina De Virgilio, PhD; Apostolos Papazacharias, MD; et al.
JAMA Psychiatry. 2013;70(9):921-930. doi:10.1001/jamapsychiatry.2013.1378.
Includes: Supplemental Content

JAMA | 
Viewpoint | 
Jacob Doll, MD; Emily Zeitler, MD; Richard Becker, MD
JAMA. 2013;310(2):145-146. doi:10.1001/jama.2013.7155.

JAMA Neurology | 
Neurological Review | 
Shoji Tsuji, MD, PhD
JAMA Neurol. 2013;70(6):689-694. doi:10.1001/jamaneurol.2013.734.
Includes: CME

JAMA Psychiatry | 
Original Article | 
Andrew E. Timms, PhD; Michael O. Dorschner, PhD; Jeremy Wechsler, MS; et al.
JAMA Psychiatry. 2013;70(6):582-590. doi:10.1001/jamapsychiatry.2013.1195.
Includes: Supplemental Content

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal
From The JAMA Network
JAMA
Health Agencies Update  | 
Public-Private Groups Seek Drug Targets
Bridget M. Kuehn, MSJ
JAMA
Viewpoint  | 
The Accelerated Approval of Oncologic Drugs:  Lessons From Ponatinib
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA
Medical News & Perspectives  | 
Another Novel Oral Anticoagulant Matches Warfarin
Mike Mitka, MSJ
JAMA Dermatology
Case Report/Case Series  | 
Identification of a Novel Complex BRAF Mutation Associated With Major Clinical Response to Vemurafenib in a Patient With Metastatic Melanoma
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.